Skip to Content

MYLAN P157 (Metformin Hydrochloride and Pioglitazone Hydrochloride 850 mg / 15 mg (base))

Pill with imprint MYLAN P157 is White, Elliptical / Oval and has been identified as Metformin Hydrochloride and Pioglitazone Hydrochloride 850 mg / 15 mg (base). It is supplied by Mylan Pharmaceuticals Inc..

Metformin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metformin/pioglitazone 850 mg / 15 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN P157

Metformin Hydrochloride and Pioglitazone Hydrochloride

Imprint
MYLAN P157
Strength
850 mg / 15 mg (base)
Color
White
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-1575

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.